ReproCELL Europe’s PM1 instrument provides real-time information on drug potency by measuring changes in the shape and form of isolated blood vessels during a pre-programmed perfusion schedule.
Our Approach
Wideblue used its product design and engineering expertise to develop a complex system combining 铿倁id handling with digital image capture and analysis. The resulting product embodies Biopta’s patented technology in a self-automated system supported by Wideblue鈥檚 custom PC application software.
Wideblue led the development of:
- The 铿倁id handling system
- Optical design of imaging system
- Electronics and 铿俹w control 铿乺mware
- Industrial design and human factors
Solution
The product was manufactured in low volume for use in a number of preclinical drug development programmes.